|
C1ORF55 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.32690000004465E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.584390E-02 |
| Normal-vs-Stage2 |
7.963700E-02 |
| Normal-vs-Stage3 |
1.13749999974821E-07 |
| Normal-vs-Stage4 |
1.56760004976775E-09 |
| Stage1-vs-Stage2 |
7.152000E-01 |
| Stage1-vs-Stage3 |
7.837600E-04 |
| Stage1-vs-Stage4 |
3.84379999995854E-06 |
| Stage2-vs-Stage3 |
5.141900E-02 |
| Stage2-vs-Stage4 |
9.901100E-03 |
| Stage3-vs-Stage4 |
2.312400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26939999999898E-05 |
| Normal-vs-AfricanAmerican |
1.62417999999276E-05 |
| Normal-vs-Asian |
9.922800E-01 |
| Caucasian-vs-AfricanAmerican |
5.280200E-02 |
| Caucasian-vs-Asian |
2.712400E-01 |
| AfricanAmerican-vs-Asian |
6.274000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.57209999976871E-07 |
| Normal-vs-Female |
3.802400E-03 |
| Male-vs-Female |
7.876400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.356160E-02 |
| Normal-vs-Age(41-60Yrs) |
3.375300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.84251999999496E-05 |
| Normal-vs-Age(81-100Yrs) |
3.344000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.677600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.522200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.969200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.824000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.998000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.986600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.302800E-01 |
| Normal-vs-Grade 2 |
2.176500E-02 |
| Normal-vs-Grade 3 |
3.97079999991945E-07 |
| Normal-vs-Grade 4 |
3.02839997523563E-09 |
| Grade 1-vs-Grade 2 |
1.454760E-01 |
| Grade 1-vs-Grade 3 |
8.541400E-03 |
| Grade 1-vs-Grade 4 |
4.412300E-04 |
| Grade 2-vs-Grade 3 |
3.056300E-03 |
| Grade 2-vs-Grade 4 |
1.85605999999394E-05 |
| Grade 3-vs-Grade 4 |
1.937510E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.229400E-01 |
| Normal-vs-ccB subtype |
2.55600000054201E-08 |
| ccA subtype-vs-ccB subtype |
5.61780000296608E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92348999999981E-05 |
| Normal-vs-N1 |
7.271700E-02 |
| N0-vs-N1 |
4.944200E-01 |
|
|
